Hosted on MSN
The truth about cloning human organs
Cloning human organs has sparked intense interest and debate in recent years, drawing attention from scientific, ethical, and medical communities. The potential for cloning human organs presents ...
Human organs could be bioprinted for transplants within 10 years, according to Lithuanian startup Vital3D. But before reaching human hearts and kidneys, the company is starting with something simpler: ...
Organs-on-chips (OoCs) represent a revolutionary advancement in the study of human physiology and disease, offering an in vitro microphysiological environment that mimics the functions of human organs ...
Miniature organs have a new lifeline. Mimicking the way early human embryos grow blood vessels, scientists nudged multiple types of mini organs to sprout their own vascular networks. Also called ...
Biotech startup eGenesis developed a gene-edited kidney that was successfully transplanted into a living patient last week. Its CEO says the company is just getting started. Last Thursday, surgeons at ...
Hosted on MSN
3D-printed organs survive 6 months in trials
In the world of medical advancements, 3D-printed organs have made a significant stride. Latest trials have demonstrated that these bioengineered organs can maintain their function for up to six months ...
In a New York operating room one day in October 2025, doctors made medical history by transplanting a genetically modified pig kidney into a living patient as part of a clinical trial. The kidney had ...
But will these “bodyoids” ever be ethically acceptable? This week, MIT Technology Review published a piece on bodyoids—living bodies that cannot think or feel pain. In the piece, a trio of experts ...
Putting pig organs in people is OK in the US, but growing human organs in pigs is not – why is that?
Monika Piotrowska does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
A frequently reported fact in the drug discovery and development industry is that approximately 90 % of drug candidates reaching clinical trials fail, with even higher amounts discarded before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results